Log on / register
Feedback | Support | My details

Email this article to a friend

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection

José M Navarro-Jarabo email, Nuria Fernández email, Francisca L Sousa email, Encarnación Cabrera email, Manuel Castro email, Luz M Ramírez email, Robin Rivera email, Esther Ubiña email, Francisco Vera email, Isabel Méndez email, Francisco Rivas-Ruiz email, José L Moreno email and Emilio Perea-Milla email

BMC Gastroenterology 2007, 7:31doi:10.1186/1471-230X-7-31

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated